The FDA has granted a priority review to a supplemental biologics license application (sBLA) for Empliciti (elotuzumab) for use in combination with Pomalyst (pomalidomide) and low-dose dexamethasone (EPd) for the treatment of patients with relapsed/refractory multiple myeloma following two or more prior therapies, including Revlimid (lenalidomide) and a proteasome inhibitor (PI).
Some days, the wind is at our back, and others, it is fighting against us. Life after cancer is all about finding pace.
There are many fears associated with cancer, but not all of them have names.
Moving on and focusing on your own future after cancer is an important step in the healing process.
In recent decades, researchers have gained a much better understanding of how gynecologic cancers develop, especially for women who carry genetic mutations.
Wistfully, I recall the days I could work all day, come home and do things around the house and then go out for dinner! Those days are long gone. I am off the chemo this week, but next week I will feel even more fatigue when I go back on.
As a person with metastatic cancer, I've surrendered a lot of my autonomy. Pay attention when I say I don't need your help.
I realized after facing my own cancer battle two years ago, I was free to fly to the other side of the "I have cancer" conversation.
A common goal for palliative care is pain management, where opioids like morphine are often on the frontline. Then, practitioners may build on medications from there, adding agents such as gabapentin and tricyclic antidepressants. But if those don’t work, Christopher J. Pietras, M.D. said that ketamine may be an option.
Talazoparib reduced the risk for disease progression or death by 46 percent and improved quality of life compared with chemotherapy in a subgroup of women with breast cancer, according to the phase 3 EMBRACA trial results.
The Food and Drug Administration (FDA) has granted a full approval to frontline Keytruda (pembrolizumab) for use in combination with standard chemotherapy for patients with metastatic nonsquamous non–small cell lung cancer (NSCLC), based on findings from the phase 3 KEYNOTE-189 trial.
CAR-T cell therapy has been showing promising in treating children with acute lymphoblastic leukemia, but it can come with significant toxicities.
While the treatment landscape of mantle cell lymphoma (MCL) has continued to evolve in recent years, researchers and clinicians alike are still at a loss for curative strategies. But immunotherapy may help.
I certainly was not used to people talking about my body all the time. "Are they taking your breast off?" several women asked. What? Who asks that question? If you do, you shouldn't.
The Food and Drug Administration (FDA) updated the prescribing information for two immunotherapy agents – Keytruda (pembrolizumab) and Tecentriq (atezolizumab) – approved to treat patients with locally advanced or metastatic bladder cancer who are not eligible for cisplatin-based therapy.
“What we really want this to do is be a place for patients to facilitate conversations with their doctor,” Michelle Woehrle, executive director of MPN Research Foundation (MPNRF) said.
A cancer survivor searches for the right way to bid farewell to a dying friend.
This is the first approval in the small cell lung cancer space in nearly two decades.
The Food and Drug Administration (FDA) approved Lenvima (lenvatinib) for the firstline treatment of patients with unresectable hepatocellular carcinoma (HCC).
Researchers noted that melanoma diagnosis and treatment did not cause many women to put off becoming pregnant.
It takes a village to support someone through a cancer diagnosis.
I call it cancer motivation. Whenever I get annoyed about doing something that's not my favorite, like a long 10K race, I think about surviving cancer and those that did not. It becomes my motivation to take a breath and enjoy each second.
Individuals diagnosed with a high frequency of basal cell carcinomas, a common type of skin cancer, may be at an increased for developing an unrelated cancer, highlighting the need for additional clinical screening.
In recent years, immunotherapy has been falling flat in the brain cancer field, but recent research may change that.
When life deals you the cancer card, make your own deck with special role models to help you remember how strong a person with cancer can be. Sometimes little reminders to ourselves in our best handwriting can help us through a rough patch.
The annual signature event has now raised more than $100 million for the V Foundation
If you're using your 'cancer following' to gain fame or profit for yourself, I ask you to reconsider.
A patient's bone health history may offer clues into their myeloma outcomes, according to a recent study.
Learning to live life with lymphedema is challenging. The life changes it presents can cause many negative emotions. but you don't have to loathe life just because you have a chronic medical condition.
Life as a cancer survivor can feel like a balancing act. One day you may be dancing with joy, and the next you might be struggling with fear. Support and understanding can come as we help people around us understand the struggle.
